AI-based methods for detecting and classifying age-related macular degeneration: a comprehensive review
Artificial Intelligence Review, ISSN: 1573-7462, Vol: 57, Issue: 9, Page: 237-237
2024
- 2Citations
- 61Usage
- 23Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations2
- Citation Indexes2
- Usage61
- Downloads53
- Abstract Views8
- Captures23
- Readers23
- 23
Article Description
This paper explores the advancements and achievements of artificial intelligence (AI) in computer vision (CV), particularly in the context of diagnosing and grading age-related macular degeneration (AMD), one of the most common leading causes of blindness and low vision that impact millions of patients globally. Integrating AI in biomedical engineering and healthcare has significantly enhanced the understanding and development of the CV application to mimic human problem-solving abilities. By leveraging AI-based models, ophthalmologists can improve the accuracy and speed of disease diagnosis, enabling early treatment and mitigating the severity of the conditions. This paper presents a comprehensive analysis of many studies on AMD published between 2014 and 2024, with more than 80% published after 2020. Various methodologies and techniques are examined, particularly emphasizing utilizing different retinal imaging modalities like color fundus photography and optical coherence tomography (OCT), where 66% of the studies used OCT datasets. This review aims to compare the efficacy of these AI-based approaches, including machine learning and deep learning, in detecting and diagnosing different stages and grades of AMD based on the evaluation of different performance metrics using different private and public datasets. In addition, this paper introduces some suggested AI solutions for future work.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85200676296&origin=inward; http://dx.doi.org/10.1007/s10462-024-10883-3; https://link.springer.com/10.1007/s10462-024-10883-3; https://zuscholars.zu.ac.ae/works/6618; https://zuscholars.zu.ac.ae/cgi/viewcontent.cgi?article=7655&context=works; https://dx.doi.org/10.1007/s10462-024-10883-3; https://link.springer.com/article/10.1007/s10462-024-10883-3
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know